Trigg, R. M., Lee, L. C., Prokoph, N., Jahangiri, L., Reynolds, C. P., Burke, G. A. A., . . . Turner, S. D. (2019). The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status. Nature Portfolio.
Style de citation Chicago (17e éd.)Trigg, Ricky M., et al. The Targetable Kinase PIM1 Drives ALK Inhibitor Resistance in High-risk Neuroblastoma Independent of MYCN Status. Nature Portfolio, 2019.
Style de citation MLA (8e éd.)Trigg, Ricky M., et al. The Targetable Kinase PIM1 Drives ALK Inhibitor Resistance in High-risk Neuroblastoma Independent of MYCN Status. Nature Portfolio, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.